Vicore Pharma Holding AB (publ) (STO:VICO)
11.34
+0.14 (1.25%)
Oct 31, 2025, 12:59 PM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 1.75M SEK in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 7.74M, down -92.57% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.
Revenue (ttm)
7.74M
Revenue Growth
-92.57%
P/S Ratio
343.69
Revenue / Employee
234.58K
Employees
29
Market Cap
2.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 109.35M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |